Estrogen Receptor Signaling Is Reprogrammed During Breast Tumorigenesis

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1819155116
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Gap Junction Β‑2 Expression Is Negatively Associated With the Estrogen Receptor Status in Breast Cancer Tissues and Is a Regulator of Breast Tumorigenesis

Oncology Reports
MedicineCancer ResearchOncology
2018English

BMPR2 Expression Is Suppressed by Signaling Through the Estrogen Receptor

Biology of Sex Differences
EndocrinologyGender Studies
2012English

Inhibition of Estrogen Receptor Signaling

Breast Cancer Online
2005English

Conditional Estrogen Receptor Knockout Mouse Model for Studying Mammary Tumorigenesis

2001English

Stimulation of Estrogen Receptor Signaling in Breast Cancer by a Novel Chaperone Synuclein Gamma

2006English

Expression of the Aryl Hydrocarbon Receptor Is Not Required for the Proliferation, Migration, Invasion, or Estrogen-Dependent Tumorigenesis of McF-7 Breast Cancer Cells

Molecular Carcinogenesis
Cancer ResearchMolecular Biology
2012English

Estrogen Receptor-Beta Is a Potential Target for Triple Negative Breast Cancer Treatment

Oncotarget
Oncology
2018English

Bisphenol AF Promotes Estrogen Receptor-Positive Breast Cancer Cell Proliferation Through Amphiregulin-Mediated Crosstalk With Receptor Tyrosine Kinase Signaling

PLoS ONE
Multidisciplinary
2019English

The Role of Cadmium and Nickel in Estrogen Receptor Signaling and Breast Cancer: Metalloestrogens or Not?

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews
MutagenesisToxicologyHealthCancer Research
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy